Show simple item record

dc.contributor.authorCannon, Dara
dc.date.accessioned2015-07-23T08:33:21Z
dc.date.available2015-07-23T08:33:21Z
dc.date.issued2010
dc.identifier.citationLaje, G,Cannon, DM,Alen, AS,Klaver, JM,Peck, SA,Liu, XM,Manji, HK,Drevets, WC,McMahon, FJ (2010) 'Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [C-11]DASB'. International Journal Of Neuropsychopharmacology, 13 :715-724.en_US
dc.identifier.urihttp://ijnp.oxfordjournals.org/content/13/6/715.abstract
dc.identifier.urihttp://hdl.handle.net/10379/5092
dc.description.abstractIn a previous study we showed that genetic variation in HTR2A, which encodes the serotonin 2A receptor, influenced outcome of citalopram treatment in patients with major depressive disorder. Since chronic administration of citalopram, which selectively and potently inhibits the serotonin transporter (5-HTT), putatively enhances serotonergic transmission, it is conceivable that genetic variation within HTR2A also influences pretreatment 5-HTT function or serotonergic transmission. The present study used positron emission tomography (PET) and the selective 5-HTT ligand, [C-11]DASB, to investigate whether the HTR2A marker alleles that predict treatment outcome also predict differences in 5-HTT binding. Brain levels of 5-HTT were assessed in vivo using PET measures of the non-displaceable component of the [C-11]DASB binding potential (BPND). DNA from 43 patients and healthy volunteers, all unmedicated, was genotyped with 14 single nucleotide polymorphisms located within or around HTR2A. Allelic association with BPND was assessed in eight brain regions, with covariates to control for race and ethnicity. We detected allelic association between [(11)]DASB BPND in thalamus and three markers in a region spanning the 3' untranslated region and second intron of HTR2A (rs7333412, p=0.000045; rs7997012, p=0.000086; rs977003, p=0.000069). The association signal at rs7333412 remained significant (pen_US
dc.formatapplication/pdfen_US
dc.language.isoenen_US
dc.relation.ispartofInternational Journal Of Neuropsychopharmacologyen
dc.subjectHTR2Aen_US
dc.subject[C-11]DASBen_US
dc.subjectGenetic associationen_US
dc.subjectPositron emission tomographyen_US
dc.subjectSerotonin transporteren_US
dc.subjectHuman brainen_US
dc.subjectBipolar Disorderen_US
dc.subjectMood disordersen_US
dc.subjectGenetic associationen_US
dc.subjectP-valuesen_US
dc.subjectH-3 paroxetineen_US
dc.subjectP-valuesen_US
dc.titleGenetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [C-11]DASBen_US
dc.typeArticleen_US
dc.date.updated2015-03-21T00:07:36Z
dc.local.publishedsourcehttp://ijnp.oxfordjournals.org/content/13/6/715.abstracten_US
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funder|~|
dc.internal.rssid1338611
dc.local.contactDara Cannon, Anatomy, Nui, Galway. 5692 Email: dara.cannon@nuigalway.ie
dc.local.copyrightcheckedNo
dc.local.versionPUBLISHED
nui.item.downloads113


Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:

Thumbnail

This item appears in the following Collection(s)

Show simple item record